Skip to content

Dr. Reddy's Laboratories

US · RDY #1451 by market cap Listed 1970
14.89 +0.06 +0.40%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 14.93 +0.67%
After-hours 15.00 +0.74%
15.2711.3014.892026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on RDY?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +15.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 3.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 41.4x Better than 13%
Forward P/E 27.0x Better than 22%
Price / Sales 3.5x Better than 35%
P/E vs own 5-yr range 99th pctl Better than 4%
Growth C+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 11.0% Better than 67%
Net income CAGR (3Y) -1.7% Better than 38%
Free cash flow CAGR (3Y) -22.9% Better than 16%
Profitability B+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 52.8% Better than 66%
Operating margin 14.9% Better than 64%
Net margin 12.8% Better than 66%
Return on equity 12.1% Better than 59%
Return on invested capital 10.3% Better than 69%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 22.2% Better than 97%
6-month return 10.3% Better than 73%
12-month return (ex latest month) -4.4% Better than 29%
Distance below 52-week high 4.3% Better than 96%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.8x Better than 51%
Debt to assets 13.3% Better than 64%
Interest coverage 15.7x Better than 79%
Free cash flow / net income 42.8% Better than 11%
Analyst View D+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 66.7% Better than 41%
Upside to average target -3.3% Better than 2%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +1.02%
1M +12.29%
3M +22.96%
6M +10.02%
YTD +6.81%
1Y +7.88%
3Y +12.43%
5Y +25.36%

Key statistics

Price & volume

Prev close
14.83
Open
14.88
Day range
14.86 - 15.10
Avg price
14.91
Volume
1.75M
Turnover
26.06M
Amplitude
1.65%
52-week range
11.28 - 15.56

Valuation

P/E
27.02
P/E (TTM)
41.36
P/B
3.00
EPS
0.55
Net profit
459.35M
Net assets
4.14B

Share structure

Market cap
12.41B
Float cap
8.94B
Shares out
833.66M
Float shares
600.65M

Dividend & listing

Dividend (TTM)
0.08
Listing date
1970-01-01
52-week range 84% of range
11.28 15.56

4.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-16.48M net over the window

Short interest

Shares short
25.30M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Dr. Reddy's Laboratories (RDY)?

Dr. Reddy's Laboratories last traded at 14.89. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Dr. Reddy's Laboratories's market cap?

About 12.41B.

What is the P/E ratio of Dr. Reddy's Laboratories?

The trailing twelve-month P/E is 41.36, above its own 5-year average of 22.59 — toward the top of its historical range (98.88% percentile). See the Valuation tab for the full history.

Does Dr. Reddy's Laboratories pay a dividend?

Yes. The trailing dividend yield is 0.56%. The 2025 payout fell 81% from 2024 - a real reduction, not rounding noise. See the Dividends tab for the full payment history.

Is Dr. Reddy's Laboratories a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 14.40, which implies 3.3% downside from the current price. This is not investment advice.

What is Dr. Reddy's Laboratories's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Dr. Reddy's Laboratories a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Dr. Reddy's Laboratories discussion 0 comments

Add a comment